NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

EQUITY (Tables)

EQUITY (Tables)

9 Months Ended

Jun. 30, 2018

Schedule of warrants issued and outstanding

Below is a table summarizing the warrants issued and outstanding as of June 30, 2018 (“Price” reflects the weighted average exercise price per share):

	Warrants			Price
Outstanding at September 30, 2017		16,178,110		$	1.23
Granted
Investor warrants		—			—
Stock-based compensation warrants		250,000			1.00
Exercised
Investor warrants		(270,000	)		1.00
Stock-based compensation warrants		—			—
Forfeited or expired
Investor warrants		—			—
Stock-based compensation warrants		(40,000	)		4.32
Outstanding at June 30, 2018		16,118,110		$	1.22
Exercisable at June 30, 2018		16,118,110		$	1.22

Schedule of assumptions used to calculate the fair value of warrants and options issued

The following assumptions were used to calculate the fair value of the Company’s warrants and options issued during the nine month period ended June 30, 2018:

	Warrants	Options
Expected term	1.59 to 2 years	3.25 to 5 years
Expected volatility	73% - 161%	101%
Expected dividends	0%	0%
Risk-free rates	1.60% - 2.27%	1.68%

Schedule of stock option activity

Below is a table summarizing the Company’s activity for the nine month period ended June 30, 2018 (“Price” reflects the weighted average exercise price per share):

	Options			Price
Outstanding at September 30, 2017		2,250,500		$	5.58
Granted		1,640,000		$	0.67
Exercised		—			—
Forfeited or expired		(758,000	)	$	6.05
Outstanding at June 30, 2018		3,132,500		$	2.89
Exercisable at June 30, 2018		1,967,494		$	4.21

Schedule of restricted stock activity

Below is a table summarizing the Company’s activity for the nine month period ended June 30, 2018:

	Shares			Weighted Average Grant Date Fair Value
Nonvested at September 30, 2017		270,179		$	4.53
Granted		—			—
Vested		(270,179	)		4.53
Forfeited		—			—
Nonvested at June 30, 2018		—			—

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details